
Keywords: HPA, hypothalamo–pituitary–adrenal; eCB, endocannabinoid; CB1, cannabinoid receptor type 1; THC, Δ9-tetrahydrocannabinol; AEA, N-arachidonylethanolamine; 2-AG, 2-arachidonoylglycerol; PEA, palmitoylethanolamide; OEA, oleoylethanolamide; ER, endoplasmic re